Delivra Health Brands (DHB.V) has a profit margin of -8.99%, below the sector sector average of 13.23%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for DHB.V is -8.99% as of March 2026. That compares with -1.06% in the prior-year period — down 745.3% year over year. That is below the sector sector average of 13.23%. Investors often review this figure alongside Delivra Health Brands's historical trend and sector peers before judging valuation or financial health.
Over the past year, DHB.V's profit margin moved from -1.06% to -8.99% — a 745.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Delivra Health Brands's valuation or profitability profile.
Against its sector companies, DHB.V currently prints -8.99% for profit margin, while the sector average sits near 13.23%. That is roughly 168.0% below the sector mean. Large gaps often invite a closer look at Delivra Health Brands's growth, margins, and balance sheet.
Profit Margin shows how effectively Delivra Health Brands converts resources into returns. At -8.99%, DHB.V may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1.06% in the prior-year period — down 745.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting DHB.V's profit margin (-8.99%), review year-over-year change from -1.06%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.